The Valley Desk

NCT03518086 · Interventional trial

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Overall registry status Completed

Phase 3

Conditions Ulcerative Colitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov